Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. CRA501-CRA501 ◽  
Author(s):  
A. Tutt ◽  
M. Robson ◽  
J. E. Garber ◽  
S. Domchek ◽  
M. W. Audeh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Parp Inhibitor ◽  
Advanced Breast ◽  
Final Text

CRA501 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 3-3 ◽  
Author(s):  
J. O'Shaughnessy ◽  
C. Osborne ◽  
J. Pippen ◽  
M. Yoffe ◽  
D. Patt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase Ii Trial ◽  
Randomized Phase Ii ◽  
Final Text

3 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]

Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer

2009 ◽  
Vol 27 (18S) ◽  
pp. CRA501-CRA501 ◽  
Author(s):  
A. Tutt ◽  
M. Robson ◽  
J. E. Garber ◽  
S. Domchek ◽  
M. W. Audeh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Parp Inhibitor ◽  
Advanced Breast

Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast Cancer

1986 ◽  
Vol 9 (4) ◽  
pp. 236-238 ◽  
Author(s):  
H.-E. Wander ◽  
D. Meyer ◽  
P. Schuff-Werner ◽  
G.A. Nagel
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast

scholarly journals Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain

2004 ◽  
Vol 15 (2) ◽  
pp. 201-206 ◽  
Author(s):  
R. Colomer ◽  
A. Llombart-Cussac ◽  
A. Lluch ◽  
A. Barnadas ◽  
B. Ojeda ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Predictive Value ◽  
Phase Ii Trial ◽  
Extracellular Domain ◽  
Advanced Breast

Phase ii trial of D-Trp-6-LH-RH in advanced breast cancer

1987 ◽  
Vol 28 ◽  
pp. 100
Author(s):  
G. Mathe ◽  
R. Helling ◽  
J. Gastlaburu ◽  
M.L.. VoVan ◽  
G. Prévot ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Lh Rh
Sign in / Sign up

Export Citation Format

Share Document